A Study to Compare the Efficacy of Arfolitixorin Versus Leucovorin in Combination With 5 Fluorouracil, Oxaliplatin, and Bevacizumab in Patients With Advanced Colorectal Cancer (AGENT)

Status:

On Hold

III

Phase

1st

Line of Therapy

Advanced / Metastatic

Disease Stage

Biomarker(s)

N/A

Investigational

Product

Arfolitixorin

Treatment Arms

o Experimental: Group A
ARFOX and Bevacizumab

o Active Comparator: Group B
mFOLFOX-6 and Bevacizumab